Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Setmelanotide in obese patients
NCT01749137Phase 2Completed
- Sponsor
- Rhythm Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- Sep 2013
- Countries
- 1
01
Overview
A Phase 2 trial of setmelanotide in obesity, sponsored by Rhythm Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
setmelanotide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT01749137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749137.